Lyka Labs Peer Comparison

NSE: LYKALABS | BSE: 500259

₹76.60

₹0.35 (0.46%)

As on 30-Oct-2026IST

Market cap

₹278 Cr

Revenue (TTM)

₹145 Cr

P/E Ratio

P/B Ratio

2.9

Div. Yield

0 %

Edit

	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Market cap (₹ Cr)	278	14,164	7,911	547
Revenue (₹ Cr)	145	4,131	979	388
Net Profit (₹ Cr)	-4.90	411.10	279.70	35.56
Net Margin (%)	-3.31	9.78	27.97	8.59
RoE (%)	-4.53	13.13	76.43	6.94
Price to Earnings	--	34.45	28.28	15.35
Price-To-Book	2.95	4.22	18.64	1.25

Income Statement (₹ Cr)

	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Operating Revenue	128.44	3,510.50	878.40	410.77
Total Income	131.94	3,582.50	896.80	431.33
Total Expenditure	131.93	2,891.50	569.40	374.67
EBITDA	-3.49	619.00	309.00	36.11
Depreciation	8.46	126.40	11.70	5.30
EBIT	-11.95	492.60	297.30	30.80
Interest	3.33	19.30	2.00	5.27
Other Income	3.50	72.00	18.40	20.56
Exceptional Items	--	-20.30	6.60	1.77
Profit before Tax	-11.78	525.00	320.30	48.27
Provision for Tax	-1.34	123.90	80.20	9.92
Profit after Tax	-10.44	401.10	240.10	38.36

	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Shareholder's Funds	92.39	3,138.70	384.00	419.77
Minority Interest	-1.56	--	--	0.00
Non-Current Liabilities	29.81	318.60	229.90	23.22
Current Liabilities	53.90	1,086.20	128.40	244.03
Total Liabilities	174.54	4,620.30	750.80	690.89

	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Non-Current Assets	111.26	1,925.10	248.00	127.78
Current Assets	63.28	2,618.40	494.30	553.60
Total Assets	174.54	4,620.30	750.80	690.89
Total Debt*	48.36	0.00	0.00	42.73
Net Current Assets	9.38	1,532.20	365.90	309.57
Contingent Liabilities	37.44	--	1.50	45.15

	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Cash From Operating Activities	5.24	650.80	174.80	0.48
Cash Flow from Investing Activities	-9.41	-512.40	7.60	-112.31
Cash from Financing Activities	4.19	-82.60	-134.50	189.66
Net Cash Inflow / Outflow	0.02	55.80	47.90	77.83

	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
ROCE (%)	-5.96	18.92	98.11	15.51
ROE (%)	-10.64	14.14	73.20	12.94
ROA (%)	-5.95	10.31	37.26	6.90
EBIT Margin (%)	0.01	19.68	37.27	13.79
Net Margin (%)	-7.91	11.20	26.77	8.89
Cash Profit Margin (%)	-1.54	15.03	27.35	10.63

	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Revenue Growth (%)	-7.26	23.64	21.24	25.75
EBIT Growth (%)	-99.94	7.72	15.44	17.94
Net Profit Growth (%)	-231.54	-1.38	32.65	-17.43
EPS Growth (%)	-225.21	-1.79	32.65	-39.83
Book Value Growth (%)	-11.84	19.89	41.18	142.48

	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Price / Earnings	0.00	26.06	43.36	16.17
Price / Book Value	1.74	3.38	27.11	1.48
Dividend Yield (%)	0.00	0.52	1.66	0.43
EV/EBITDA	0.00	14.57	30.65	8.02
Market Cap (₹ Cr)	159.68	10,450.76	10,410.62	620.31

	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Debt to Equity	0.53	0.00	0.00	0.10
Short term debt to equity ratio	0.21	--	--	0.10
Current Ratio	1.17	2.41	3.85	2.27
Quick Ratio	0.92	2.41	3.37	2.18
Interest Coverage	-2.54	28.20	161.15	10.17

	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Debtors to sales (%)	27.28	27.97	3.37	58.80
Asset Turnover	0.73	0.90	1.43	0.74
Receivable days	110.99	90.10	8.58	174.27
Inventory Days	37.08	0.00	20.38	35.88
Payable days	115.42	--	118.89	181.60
Cash Conversion Cycle	32.64	--	-89.93	28.56

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.